Your browser doesn't support javascript.
loading
Inflammatory myofibroblastic disease of right petrous apex: A rare case with review of literature.
Mahadev, Doddala Sankara; Praveen, N V S; Suryadevara, Aparna; Naga Kishore, M G.
Afiliación
  • Mahadev DS; Nuclear Medicine, King George Hospital, Andhra Medical College, Visakhapatnam, Andhra Pradesh, India.
  • Praveen NVS; Consultant Radiation Oncologist, Omega Hospital, Guntur, Andhra Pradesh, India.
  • Suryadevara A; Department of Radiation Oncology, Mehdi Nawaz Jung Institute of Oncology and Regional Cancer Centre, Hyderabad, Telangana, India.
  • Naga Kishore MG; Consultant Surgical Oncologist, Omega Hospital, Guntur, Andhra Pradesh, India.
J Cancer Res Ther ; 20(3): 1077-1080, 2024 Apr 01.
Article en En | MEDLINE | ID: mdl-38261452
ABSTRACT
ABSTRACT Inflammatory myofibroblastic tumor (IMFT) is a rare tumor of unknown etiology. It can involve any part of the body. The IMFT involving the base of skull is rare with only 36 cases reported in the literature. We report a rare case of IMFT of temporal bone with review of literature. A 42 year old male presented with complaints of headache and double vision and MRI brain showed lesion in the right petrous apex region suggestive of a neurogenic mass. He had excision of lesion and histopathology was suggestive of IMFT with IgG4 and ALK positive. He had complete clinical response but a month later he presented with right eyelid ptosis and decreased rotation of eye medially with recurrent lesion on MRI. Patient received radiation by SRT technique and then started on Ceretinib with partial response. The IMFT is rare tumor of unknown etiology and tumors of temporal bone are more aggressive. It is benign but locally invasive tumor. Treatment of IMFT is controversial. Extensive surgery with complete excision has about 80% response rates and with intracranial extension, adjuvant radiation is need. In head and neck IMFT response rates are lower (30 to 40%). Monoclonal antibodies and steroids are used in IMFT at recurrence. In advanced or metastatic ALK positive tumors, Crizotinib is used with a response rate of 50%. Radiotherapy (25 to 30 Gy) induces remission and helps to taper the steroids. Temporal bone IMFT is a rare tumor with multimodality approach and variable response to treatment.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Granuloma de Células Plasmáticas Límite: Adult / Humans / Male Idioma: En Revista: J Cancer Res Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: India Pais de publicación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Granuloma de Células Plasmáticas Límite: Adult / Humans / Male Idioma: En Revista: J Cancer Res Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: India Pais de publicación: India